Interstitial cystitis - intravesical treatment

Abstract

Interstitial cystitis (IC), also known as Bladder Pain Syndrome (BPS) is a chronic disease of unknown etiology and progressive in nature characterized by the presence of pain and accompanied by irritating urinary symptoms in the absence of other identifiable causes1. Since it was first described by Skene in 1887, who characterized it is an inflammatory process that involves the entire or part of the bladder mucosa and can reach the muscle wall, studies on its etiology and physiopathology have not been successful in elucidating its specific mechanism. Thus, the therapeutic approach is a complex subject that includes behavioral, pharmacological and even surgical interventions with the main objective of restoring the bladder function, preventing recurrence and improving the quality of life2.